CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
-13.82%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$6.51B
AUM Growth
-$1.02B
(-13%)
Cap. Flow
+$50.5M
Cap. Flow
% of AUM
0.78%
Top 10 Holdings %
Top 10 Hldgs %
20.49%
Holding
900
New
86
Increased
331
Reduced
275
Closed
84
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
+$52.9M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$29.4M |
| 3 |
Biogen
BIIB
|
+$18.6M |
| 4 |
Mastercard
MA
|
+$17.7M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$17.5M |
Top Sells
| 1 |
TSRO
TESARO, Inc.
TSRO
|
+$50.7M |
| 2 |
Ecopetrol
EC
|
+$21.5M |
| 3 |
AET
Aetna Inc
AET
|
+$20.2M |
| 4 |
Amgen
AMGN
|
+$19.2M |
| 5 |
Merck
MRK
|
+$18.5M |
Sector Composition
| 1 | Healthcare | 35.32% |
| 2 | Technology | 15.37% |
| 3 | Financials | 11.61% |
| 4 | Consumer Discretionary | 8.19% |
| 5 | Communication Services | 7.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
Ligand Pharmaceuticals
LGND
$3.24B
| $2.04M | 0.03% |
+24,045
| New | +$2.04M |
|
452
Amphenol
APH
$145B
| $2.02M | 0.03% |
99,908
-6,652
| -6% | -$135K |
|
453
T Rowe Price
TROW
$23.4B
| $2.01M | 0.03% |
21,717
-2,839
| -12% | -$262K |
|
|
EIDX
454
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $2M | 0.03% |
+145,000
| New | +$2M |
|
|
EGL
455
DELISTED
Engility Holdings, Inc.
EGL
| $1.98M | 0.03% |
69,669
| – | – |
|
456
Principal Financial Group
PFG
$17.8B
| $1.98M | 0.03% |
44,821
-3,939
| -8% | -$174K |
|
457
NetApp
NTAP
$24.7B
| $1.97M | 0.03% |
32,982
-125,124
| -79% | -$7.47M |
|
458
State Street
STT
$31.4B
| $1.97M | 0.03% |
31,163
+645
| +2% | +$40.7K |
|
459
Loews
L
$19.9B
| $1.95M | 0.03% |
42,914
+2,727
| +7% | +$124K |
|
460
Canadian Natural Resources
CNQ
$64.9B
| $1.94M | 0.03% |
163,846
+29
| +0% | +$342 |
|
461
Campbell Soup
CPB
$9.98B
| $1.92M | 0.03% |
58,204
-25,306
| -30% | -$835K |
|
462
AvalonBay Communities
AVB
$27.4B
| $1.92M | 0.03% |
11,026
+519
| +5% | +$90.3K |
|
463
Manulife Financial
MFC
$52.4B
| $1.91M | 0.03% |
134,389
-25,418
| -16% | -$360K |
|
464
O'Reilly Automotive
ORLY
$89.2B
| $1.87M | 0.03% |
81,465
-5,145
| -6% | -$118K |
|
465
Quest Diagnostics
DGX
$20.1B
| $1.85M | 0.03% |
22,273
+7,584
| +52% | +$631K |
|
466
Infosys
INFY
$70.4B
| $1.84M | 0.03% |
193,606
+85,126
| +78% | +$810K |
|
467
Darden Restaurants
DRI
$24.7B
| $1.83M | 0.03% |
18,363
+5,093
| +38% | +$509K |
|
468
Cheniere Energy
LNG
$52.1B
| $1.82M | 0.03% |
30,735
+11,306
| +58% | +$669K |
|
469
Rogers Communications
RCI
$19.1B
| $1.82M | 0.03% |
35,484
-484
| -1% | -$24.8K |
|
470
AutoZone
AZO
$71.1B
| $1.79M | 0.03% |
2,140
-243
| -10% | -$204K |
|
471
Dover
DOV
$24.1B
| $1.77M | 0.03% |
24,968
-1,603
| -6% | -$114K |
|
|
DOVA
472
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
| $1.77M | 0.03% |
233,200
| – | – |
|
473
McKesson
MCK
$87.8B
| $1.75M | 0.03% |
15,867
-29,417
| -65% | -$3.25M |
|
474
Autoliv
ALV
$9.63B
| $1.73M | 0.03% |
24,638
+816
| +3% | +$57.3K |
|
475
TransDigm Group
TDG
$72.5B
| $1.72M | 0.03% |
5,051
-422
| -8% | -$144K |
|